Anti-CPT1A antibody [EPR21843-71-2F] (Ab234111)

CPT1, CPT1A, CPT1-L, Carnitine palmitoyltransferase 1A, Succinyltransferase CPT1A, CPT I, CPTI-L

反应种属:Human, Mouse, Rat
抗原名称:CPT1A
应用:WB, IHC, FCM

用户验证的应用

推荐稀释比例

  • IHC-P1/1000
  • WB1/1000

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Monoclonal
全称Anti-CPT1A antibody [EPR21843-71-2F]
产品形式Liquid
储存缓冲液pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
储存条件运输条件: Conditional Ambient 推荐的短期储存时间: 1-2 weeks 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle
纯化方式Affinity purification Protein A

背景信息

What is this antibody validated in? Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples. What is the molecular weight of CPT1A? Anti-CPT1A [EPR21843-71-2F] (ab234111) specifically detects a band for CPT1A (UniProt: P50416) at a molecular weight of 88kDa. Trusted by the scientific community Anti-CPT1A [EPR21843-71-2F] (ab234111) was first used in a scientific publication in 2018 and has been cited over 30 times in peer-reviewed journals. Specificity confirmed The specificity of Anti-CPT1A antibody [EPR21843-71-2F] (ab234111) has been confirmed by Western blot testing in CPT1A Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [EPR21843-71-2F] also available for your convenience: ab234111, Carrier free - ab235841 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.

文献引用 (75)

Hyperimonates A and B, a pair of unprecedented polyprenylated acylphloroglucinols from Hypericum monogynum: Structural elucidation, total synthesis, and lipid-lowering activity.

金丝桃酸酯 A 和 B,一对来自金丝桃属单子叶金丝桃的前所未有的多异戊二烯酰基间苯三酚:结构阐明、全合成和降脂活性。

Hyodeoxycholic acid attenuates atherosclerosis by antagonizing FXR and modulating the PD-1/mTORC1 signaling axis.

脱氧胆酸通过拮抗 FXR 和调节 PD-1/mTORC1 信号轴来减轻动脉粥样硬化。

Yang Feng, Huang Wenqiong, Meng Zongzhen, Liu Meijun, Lyu Aiping, Mauro Claudio, Cheung Kenneth C P

Protective role of fatty acid oxidation against epithelial barrier dysfunction in allergic asthma.

脂肪酸氧化对过敏性哮喘上皮屏障功能障碍的保护作用。

Wang Muyun, He Yanan, Hu Haiyang, Wu Di, Liao Ximing, Gao Jing, Gao Shaoyong, Yin Huiming, Chung Kian Fan, Li Qiang, Wang Kun, Gao Wei

Quercetin-4'-O-β-D-glucopyranoside inhibits ferroptosis though SIRT5-mediated desuccinylation of TFR1 in diabetic nephropathy.

槲皮素-4'-O-β-D-吡喃葡萄糖苷通过 SIRT5 介导的 TFR1 去琥珀酰化抑制糖尿病肾病中的铁死亡。

Wu Menghua, Ye Weifeng, Ye Xiaoli

Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis mice.

托格列净可减轻非糖尿病非酒精性脂肪性肝炎小鼠的肝脏脂肪变性和纤维化。

Ozono Yoshinori, Kawakami Hiroshi, Hatada Hiroshi, Uchiyama Naomi, Ogawa Souichiro, Uchida Keisuke, Tamura Hotaka, Komaki Yuri, Nakamura Kenichi, Iwakiri Hisayoshi, Hasuike Satoru, Nagata Kenji

β-Alanine alleviated non-alcoholic fatty liver disease via regulation of hepatic sulfur-amino acid metabolism in mice.

β-丙氨酸通过调节小鼠肝脏硫氨基酸代谢来缓解非酒精性脂肪肝疾病。

High-dose taurine supplementation exacerbates alcohol-associated liver disease by inducing gut microbiota dysbiosis and bile acid dysregulation in mice.

高剂量牛磺酸补充剂会通过诱导小鼠肠道菌群失调和胆汁酸失调,加剧酒精相关性肝病。

Pei Jingdan, Chen Lixian, Pushparaj Rahul, Huang Panpan, Pan Guihua, Sun Chunbao, Gao Xing, Zhang Lihua, Manirujjaman Md, Huang Chiung-Kuei, Ting Peng-Sheng, Deng Zhongbin, Chen Shaoyu, Zhang Xiang, Vatsalya Vatsalya, McClain Craig J, Feng Wenke

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation

索拉非尼通过促进 PPARα 介导的脂肪酸氧化增强肝细胞癌中髓源性抑制细胞的功能

Chunxiao Li #, Liting Xiong #, Yuhan Yang #, Ping Jiang, Junjie Wang, Mengyuan Li, Shuhua Wei, Suqing Tian, Yuexuan Wang, Mi Zhang, Jie Tang

Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation

通过 Etomoxir 抑制 CPT1 逆转代谢重编程,通过 DUSP1 ADP 核糖基化介导的 p38 MAPK 磷酸化促进心肌细胞增殖和心脏再生

Luxun Tang, Yu Shi, Qiao Liao, Feng Wang, Hao Wu, Hongmei Ren, Xuemei Wang, Wenbin Fu, Jialing Shou, Wei Eric Wang, Pedro A Jose, Yongjian Yang, Chunyu Zeng

Loss of SLC25A20 in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat Diet

胰腺腺癌中SLC25A20的缺失逆转了高脂饮食的促肿瘤作用

Sang Myung Woo ,Ho Lee ,Joon Hee Kang ,Mingyu Kang ,Wonyoung Choi ,Sung Hoon Sim ,Jung Won Chun ,Nayoung Han ,Kyung-Hee Kim ,Woojin Ham ,Woosol Hong ,Chaeyoung Kim ,Jeong Hwan Park ,Dawool Han ,Jong In Yook ,Woo Jin Lee ,Soo-Youl Kim
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 8